On Wednesday, September 10, 2014, the NASDAQ Composite ended at 4,592.29, up 0.20%, the Dow Jones Industrial Average declined 0.15%, to finish the day at 17,111.42, and the S&P 500 closed at 2,001.54, down 0.31%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 741.59, up 0.05%, with the index also advancing 6.75% in the previous three months.
Technews has researched on the following equities: Keryx Biopharmaceuticals Inc. KERX, -0.01% Sangamo BioSciences Inc. SGMO, +5.92% Regeneron Pharmaceuticals Inc. REGN, +2.38% Sunesis Pharmaceuticals Inc. SNSS, +3.65% and Idera Pharmaceuticals Inc. IDRA, -0.38%. This article covers these biotech stocks and
Biotech Stock News
On Monday, shares in Keryx Biopharmaceuticals Inc. traded between $14.82 and $16.50 before ending the session 11.17% lower at $15.11. The stock reported a trading volume of 13.35 million shares, significantly above its three months average volume of 1.79 million shares.
Sangamo BioSciences Inc.’s stock advanced 3.48%, to close the day at $12.77. The stock recorded a trading volume of 0.71 million shares, below its three months average volume of 0.82 million shares. The stock oscillated between $12.32 and $12.91 during the session. Over the last three trading sessions and over the past one month, Sangamo BioSciences Inc.’s shares have fallen by 1.08% and 7.40%, respectively.
On Monday, shares in Regeneron Pharmaceuticals Inc. recorded a trading volume of 0.65 million shares, lower than its three months average volume of 0.84 million shares. The stock ended the day at $348.10, which was 0.73% below its previous day’s closing of $350.66, and registered an intraday range of $343.18 and $351.00.
Sunesis Pharmaceuticals Inc.‘s stock surged 3.94%, to close Monday’s session at $7.38, after oscillating between $7.11 and $7.47. The stock recorded a trading volume of 0.86 million shares, above its three months average volume of 0.75 million shares. Sunesis Pharmaceuticals Inc.’s shares have surged 10.15% in the last one month and 40.57% in the previous three months.
Biotech News Video
Watch this video for more “Biotech” news.
Biotech Financial News
Idera Pharmaceuticals Inc.’s stock finished Monday’s session 2.60% higher at $2.76. A total of 0.67 million shares were traded, which was below its three months average volume of 1.39 million shares.
Thanks for visiting the TechNews.org website. Be sure to catch all BioTech financial news, bookmark us and check all the videos and news articles regarding Biotech business news.